Sotera Health Company
SHC
Positions held
Your positionsSHC isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Sotera Health Company operates in the growing diagnostics and research sector, which is expected to see increased demand as healthcare needs evolve.
- Revenue increased by 15% from the prior quarter, reaching $321 million.
- Gross margin improved to 55.4%, up from 52.5% in the previous quarter.
- The company has a high debt-to-equity ratio of 340.73, indicating potential financial risk.
- Trailing P/E ratio stands at 32.02, suggesting the stock may be overvalued compared to earnings.
- The current market sentiment is neutral with a score of 2.00, indicating mixed investor confidence.
Fundamentals
| Market cap | $5.09B | Enterprise value | $7.00B | Trailing P/E | 31.28 | Forward P/E | 16.57 |
| PEG | 1.31 | Price / book | 7.64 | Beta | 1.86 | Dividend yield | 0.00% |
| Revenue growth | 9.2% | Earnings growth | 569.5% | Gross margin | 55.0% | Operating margin | 38.0% |
| Profit margin | 13.4% | ROE | 27.8% | ROA | 8.6% | Debt / equity | 3.41 |
| Current ratio | 2.80 | Free cash flow | $153.97M | Analyst recommendation | buy | Mean target | $22.72 |
| 52w high | $19.85 | 52w low | $13.09 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $321M | $280M | $303M | $311M | $294M | — |
| Op margin | 33.2% | 27.1% | 34.7% | 35.7% | 30.0% | — |
| Net income | $53.6M | $26.6M | $34.8M | $48.4M | $8.0M | — |
| Gross margin | 55.4% | 52.5% | 54.7% | 57.0% | 56.6% | — |
| Gross profit | $178M | $147M | $166M | $178M | $167M | — |
| Operating income | $107M | $75.8M | $105M | $111M | $88.4M | — |
- Revenue +15% vs prior quarter ($321M vs $280M).
- Gross margin 55.4% (was 52.5% prior quarter).
- Operating margin expanded to 33.2%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.1B | $1.0B | $1.0B | — |
| Op margin | 31.1% | 27.0% | 26.4% | 24.7% | — |
| Net income | $77.9M | $44.4M | $51.4M | -$234M | — |
| Gross margin | 55.5% | 54.7% | 55.0% | 55.5% | — |
| Gross profit | $646M | $602M | $577M | $557M | — |
| Operating income | $362M | $298M | $277M | $248M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-15 · Here’s Why Sotera Health Company (SHC) Surges 25% in Q2
2026-09-14 · 3 of Wall Street’s Favorite Stocks We Approach with Caution
2026-08-24 · 3 Profitable Stocks We Think Twice About
2026-08-19 · Research Tools & Consumables Stocks Q2 Recap: Benchmarking Sotera Health Company (NASDAQ:SHC)
2026-08-16 · Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings?
2026-08-15 · Sotera Health Company’s Q2 Earnings Call: Our Top 5 Analyst Questions
2026-08-13 · Sotera Health (SHC) Q2 2026 Earnings Call Transcript
2026-08-12 · 3 Healthcare Stocks with Open Questions
2026-08-10 · Sotera Health Company (SHC) Reported Positive Results Amid Litigation Wins
2026-08-10 · SHC Q2 Deep Dive: Broad-Based Growth, Leadership Transition, and Strategic Investments Shape Outlook
2026-08-07 · Sotera Health (SHC) Is Up 5.9% After Q2 Earnings Beat And Guidance Hike What’s Changed
2026-08-07 · Sotera Health Q2 Earnings Call Highlights
Price (daily)
Full chart · RSI · MACD · patterns